ContractWorldwide License Agreement • February 9th, 2022Contract TypeWorldwide License AgreementFiledFebruary 9th, 2022AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus
AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus